ReP USP - Resultado da busca

Artigo de periodico
Exploring the impact of Anaplasma phagocytophilum on colonization resistance of Ixodes scapularis microbiota using network node manipulation (2024)
Abuin-Denis, Lianet ; Piloto-Sardiñas, Elianne ; Maître, Apolline ; Wu-Chuang, Alejandra ; Mateos-Hernández, Lourdes ; Obregon, Dasiel ; Corona-González, Belkis ; Palinauskas, Vaidas ; Aželytė, Justė ; Rodríguez-Mallon, Alina ; Cabezas-Cruz, Alejandro ; Fogaça, Andréa Cristina
Fonte: Current Research in Parasitology and Vector-Borne Diseases. Unidade: ICB
Assuntos: PARASITOLOGIA, CARRAPATOS, ANAPLASMATACEAE, SEQUENCIAMENTO GENÉTICO, INFECÇÕES BACTERIANAS GRAM-NEGATIVAS, BIODIVERSIDADE, DIVERSIDADE GENÉTICA, FILOGENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABUIN-DENIS, Lianet et al. Exploring the impact of Anaplasma phagocytophilum on colonization resistance of Ixodes scapularis microbiota using network node manipulation. Current Research in Parasitology and Vector-Borne Diseases, v. 5, p. 11 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.crpvbd.2024.100177. Acesso em: 14 nov. 2024.
APA
Abuin-Denis, L., Piloto-Sardiñas, E., Maître, A., Wu-Chuang, A., Mateos-Hernández, L., Obregon, D., et al. (2024). Exploring the impact of Anaplasma phagocytophilum on colonization resistance of Ixodes scapularis microbiota using network node manipulation. Current Research in Parasitology and Vector-Borne Diseases, 5, 11 . doi:10.1016/j.crpvbd.2024.100177
NLM
Abuin-Denis L, Piloto-Sardiñas E, Maître A, Wu-Chuang A, Mateos-Hernández L, Obregon D, Corona-González B, Palinauskas V, Aželytė J, Rodríguez-Mallon A, Cabezas-Cruz A, Fogaça AC. Exploring the impact of Anaplasma phagocytophilum on colonization resistance of Ixodes scapularis microbiota using network node manipulation [Internet]. Current Research in Parasitology and Vector-Borne Diseases. 2024 ; 5 11 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.crpvbd.2024.100177
Vancouver
Abuin-Denis L, Piloto-Sardiñas E, Maître A, Wu-Chuang A, Mateos-Hernández L, Obregon D, Corona-González B, Palinauskas V, Aželytė J, Rodríguez-Mallon A, Cabezas-Cruz A, Fogaça AC. Exploring the impact of Anaplasma phagocytophilum on colonization resistance of Ixodes scapularis microbiota using network node manipulation [Internet]. Current Research in Parasitology and Vector-Borne Diseases. 2024 ; 5 11 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.crpvbd.2024.100177
Artigo de periodico
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (2023)
Matuozzo, Daniela ; Talouarn, Estelle ; Marchal, Astrid; Manry, Jeremy; Seeleuthner, Yoann; Zhang, Yu; Bolze, Alexandre ; Chaldebas, Matthieu; Condino Neto, Antonio ; Zatz, Mayana
Fonte: Genome Medicine. Unidades: IB, ICB
Assuntos: IMUNOLOGIA, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATUOZZO, Daniela et al. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. Genome Medicine, v. 15, p. 1-25, 2023Tradução . . Disponível em: https://doi.org/10.1186/s13073-023-01173-8. Acesso em: 14 nov. 2024.
APA
Matuozzo, D., Talouarn, E., Marchal, A., Manry, J., Seeleuthner, Y., Zhang, Y., et al. (2023). Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. Genome Medicine, 15, 1-25. doi:10.1186/s13073-023-01173-8
NLM
Matuozzo D, Talouarn E, Marchal A, Manry J, Seeleuthner Y, Zhang Y, Bolze A, Chaldebas M, Condino Neto A, Zatz M. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 [Internet]. Genome Medicine. 2023 ; 15 1-25.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1186/s13073-023-01173-8
Vancouver
Matuozzo D, Talouarn E, Marchal A, Manry J, Seeleuthner Y, Zhang Y, Bolze A, Chaldebas M, Condino Neto A, Zatz M. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 [Internet]. Genome Medicine. 2023 ; 15 1-25.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1186/s13073-023-01173-8
Artigo de periodico
Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients (2023)
Yurchenko, Andrey A. ; Rajabi, Fatemeh ; Braz-Petta, Tirzah ; Fassihi, Hiva ; Lehmann, Alan ; Nishigori, Chikako ; Wang, Jinxin; Padioleau, Ismael ; Gunbin, Konstantin ; Panunzi, Leonardo ; Morice-Picard, Fanny ; Laplante, Pierre; Robert, Caroline ; Kannouche, Patricia L. ; Sarasin, Alain ; Nikolaev, Sergey I. ; Menck, Carlos Frederico Martins
Fonte: Nature Communications. Unidade: ICB
Assuntos: MICROBIOLOPGIA, MUTAÇÃO GENÉTICA, REPARAÇÃO DE DNA, NEOPLASIAS CUTÂNEAS, DERMATOPATIAS, DOENÇAS GENÉTICAS, RADIAÇÃO ULTRAVIOLETA, GENÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YURCHENKO, Andrey A. et al. Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients. Nature Communications, v. 14, p. 1-17, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41467-023-38311-0. Acesso em: 14 nov. 2024.
APA
Yurchenko, A. A., Rajabi, F., Braz-Petta, T., Fassihi, H., Lehmann, A., Nishigori, C., et al. (2023). Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients. Nature Communications, 14, 1-17. doi:10.1038/s41467-023-38311-0
NLM
Yurchenko AA, Rajabi F, Braz-Petta T, Fassihi H, Lehmann A, Nishigori C, Wang J, Padioleau I, Gunbin K, Panunzi L, Morice-Picard F, Laplante P, Robert C, Kannouche PL, Sarasin A, Nikolaev SI, Menck CFM. Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients [Internet]. Nature Communications. 2023 ; 14 1-17.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41467-023-38311-0
Vancouver
Yurchenko AA, Rajabi F, Braz-Petta T, Fassihi H, Lehmann A, Nishigori C, Wang J, Padioleau I, Gunbin K, Panunzi L, Morice-Picard F, Laplante P, Robert C, Kannouche PL, Sarasin A, Nikolaev SI, Menck CFM. Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients [Internet]. Nature Communications. 2023 ; 14 1-17.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41467-023-38311-0
Artigo de periodico
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency (2023)
Voyer, Tom Le ; Parent, Audrey V ; Liu, Xian ; Cederholm, Axel ; Condino Neto, Antonio ; Vidigal, Mateus; Zatz, Mayana
Fonte: Nature. Unidades: ICB, IB
Assuntos: AUTOANTICORPOS, IMUNOLOGIA, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VOYER, Tom Le et al. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency. Nature, v. 623, p. 803–813, 2023Tradução . . Disponível em: https://doi-org.ez67.periodicos.capes.gov.br/10.1038/s41586-023-06717-x. Acesso em: 14 nov. 2024.
APA
Voyer, T. L., Parent, A. V., Liu, X., Cederholm, A., Condino Neto, A., Vidigal, M., & Zatz, M. (2023). Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency. Nature, 623, 803–813. doi:10.1038/s41586-023-06717-x
NLM
Voyer TL, Parent AV, Liu X, Cederholm A, Condino Neto A, Vidigal M, Zatz M. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency [Internet]. Nature. 2023 ; 623 803–813.[citado 2024 nov. 14 ] Available from: https://doi-org.ez67.periodicos.capes.gov.br/10.1038/s41586-023-06717-x
Vancouver
Voyer TL, Parent AV, Liu X, Cederholm A, Condino Neto A, Vidigal M, Zatz M. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency [Internet]. Nature. 2023 ; 623 803–813.[citado 2024 nov. 14 ] Available from: https://doi-org.ez67.periodicos.capes.gov.br/10.1038/s41586-023-06717-x
Artigo de periodico
Advancing respiratory–cardiovascular physiology with the working heart–brainstem preparation over 25 years (2022)
Paton, Julian F. R. ; Machado, Benedito Honório ; Moraes, Davi José de Almeida ; Zoccal, Daniel Breseghello ; Sheikh, Ana Paula Abdala ; Smith, Jeffrey C.; Antunes, Vagner Roberto ; Murphy, David; Dutschmann, Mathias
Fonte: Journal of Physiology. Unidades: FMRP, ICB
Assuntos: FISIOLOGIA, FISIOLOGIA RESPIRATÓRIA E CIRCULATÓRIA, FISIOLOGIA CARDIOVASCULAR, TRONCO CEREBRAL, ANÓXIA, HIPERTENSÃO, CORAÇÃO, PULMÃO, CAMUNDONGOS, RATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PATON, Julian F. R. et al. Advancing respiratory–cardiovascular physiology with the working heart–brainstem preparation over 25 years. Journal of Physiology, v. 600, n. 9, p. 2049-2075, 2022Tradução . . Disponível em: https://doi.org/10.1113/JP281953. Acesso em: 14 nov. 2024.
APA
Paton, J. F. R., Machado, B. H., Moraes, D. J. de A., Zoccal, D. B., Sheikh, A. P. A., Smith, J. C., et al. (2022). Advancing respiratory–cardiovascular physiology with the working heart–brainstem preparation over 25 years. Journal of Physiology, 600( 9), 2049-2075. doi:10.1113/JP281953
NLM
Paton JFR, Machado BH, Moraes DJ de A, Zoccal DB, Sheikh APA, Smith JC, Antunes VR, Murphy D, Dutschmann M. Advancing respiratory–cardiovascular physiology with the working heart–brainstem preparation over 25 years [Internet]. Journal of Physiology. 2022 ; 600( 9): 2049-2075.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1113/JP281953
Vancouver
Paton JFR, Machado BH, Moraes DJ de A, Zoccal DB, Sheikh APA, Smith JC, Antunes VR, Murphy D, Dutschmann M. Advancing respiratory–cardiovascular physiology with the working heart–brainstem preparation over 25 years [Internet]. Journal of Physiology. 2022 ; 600( 9): 2049-2075.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1113/JP281953
Artigo de periodico
Immunization with CSP and a RIG-I agonist is effective in inducing a functional and protective humoral response against Plasmodium (2022)
Teixeira, Ana Rafaela ; Cabezas, Begoña Pérez ; Costa, David Alexandre Mendes ; Sá, Mónica ; Golba, Sylvain ; Djemaoune, Hélèna Sefiane; Ribeiro, Joana; Kaneko, Izumi; Iwanaga, Shiroh ; Yuda, Masao ; Tsuji, Moriya ; Boscardin, Silvia Beatriz ; Amino, Rogerio ; Silva, Anabela Cordeiro da ; Tavares, Joana
Fonte: Frontiers in Immunology. Unidade: ICB
Assuntos: PARASITOLOGIA, PLASMODIUM FALCIPARUM, MODELOS ANIMAIS DE DOENÇAS, RATOS, ADJUVANTES IMUNOLÓGICOS, IMUNIZAÇÃO, VACINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIXEIRA, Ana Rafaela et al. Immunization with CSP and a RIG-I agonist is effective in inducing a functional and protective humoral response against Plasmodium. Frontiers in Immunology, v. 13, p. 1-19, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.868305. Acesso em: 14 nov. 2024.
APA
Teixeira, A. R., Cabezas, B. P., Costa, D. A. M., Sá, M., Golba, S., Djemaoune, H. S., et al. (2022). Immunization with CSP and a RIG-I agonist is effective in inducing a functional and protective humoral response against Plasmodium. Frontiers in Immunology, 13, 1-19. doi:10.3389/fimmu.2022.868305
NLM
Teixeira AR, Cabezas BP, Costa DAM, Sá M, Golba S, Djemaoune HS, Ribeiro J, Kaneko I, Iwanaga S, Yuda M, Tsuji M, Boscardin SB, Amino R, Silva AC da, Tavares J. Immunization with CSP and a RIG-I agonist is effective in inducing a functional and protective humoral response against Plasmodium [Internet]. Frontiers in Immunology. 2022 ; 13 1-19.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3389/fimmu.2022.868305
Vancouver
Teixeira AR, Cabezas BP, Costa DAM, Sá M, Golba S, Djemaoune HS, Ribeiro J, Kaneko I, Iwanaga S, Yuda M, Tsuji M, Boscardin SB, Amino R, Silva AC da, Tavares J. Immunization with CSP and a RIG-I agonist is effective in inducing a functional and protective humoral response against Plasmodium [Internet]. Frontiers in Immunology. 2022 ; 13 1-19.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3389/fimmu.2022.868305
Artigo de periodico-carta/editorial
Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β (2021)
Vinh, Donald C. ; Abel, Laurent ; Bastard, Paul ; Cheng, Matthew P. ; Condino Neto, Antonio ; Gregersen, Peter K. ; Haerynck, Filomeen ; Cicalese, Maria-Pia ; Hagin, David; Palacín, Pere Soler ; Planas, Anna M. ; Pujol, Aurora ; Notarangelo, Luigi D. ; Zhang, Qian ; Su, Helen C. ; Casanova, Jean-Laurent ; Meyts, Isabelle
Fonte: Journal of Clinical Immunology. Unidade: ICB
Assuntos: IMUNOLOGIA, IMUNIDADE, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, IMUNOGENÉTICA, COVID-19, INTERFERON TIPO I, INFECÇÕES POR CORONAVIRUS, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VINH, Donald C. et al. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β. Journal of Clinical Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s10875-021-01068-6. Acesso em: 14 nov. 2024. , 2021
APA
Vinh, D. C., Abel, L., Bastard, P., Cheng, M. P., Condino Neto, A., Gregersen, P. K., et al. (2021). Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β. Journal of Clinical Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1007/s10875-021-01068-6
NLM
Vinh DC, Abel L, Bastard P, Cheng MP, Condino Neto A, Gregersen PK, Haerynck F, Cicalese M-P, Hagin D, Palacín PS, Planas AM, Pujol A, Notarangelo LD, Zhang Q, Su HC, Casanova J-L, Meyts I. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β [Internet]. Journal of Clinical Immunology. 2021 ; 1-18.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/s10875-021-01068-6
Vancouver
Vinh DC, Abel L, Bastard P, Cheng MP, Condino Neto A, Gregersen PK, Haerynck F, Cicalese M-P, Hagin D, Palacín PS, Planas AM, Pujol A, Notarangelo LD, Zhang Q, Su HC, Casanova J-L, Meyts I. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β [Internet]. Journal of Clinical Immunology. 2021 ; 1-18.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/s10875-021-01068-6
Artigo de periodico
A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection (2021)
Andreakos, Evangelos ; Abel, Laurent ; Vinh, Donald C. ; Kaja, Elzbieta ; Drolet, Beth A. ; Zhang, Qian ; O\2019Farrelly, Cliona ; Novelli, Giuseppe ; Gallego, Carlos Rodríguez ; Haerynck, Filomeen ; Prando, Carolina ; Pujol, Aurora ; Condino Neto, Antonio ; Zatz, Mayana
Fonte: Nature Immunology. Unidades: ICB, IB
Assuntos: IMUNOLOGIA, INFECÇÕES POR CORONAVIRUS, GENÉTICA MÉDICA, INTERFERON TIPO I, QUIMIOCINAS, PLASMODIUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDREAKOS, Evangelos et al. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology, p. 1-6, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41590-021-01030-z. Acesso em: 14 nov. 2024.
APA
Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., et al. (2021). A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology, 1-6. doi:10.1038/s41590-021-01030-z
NLM
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Zatz M. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ; 1-6.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41590-021-01030-z
Vancouver
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Zatz M. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ; 1-6.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41590-021-01030-z
Artigo de periodico
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021)
Bastard, Paul ; Gervais, Adrian ; Voyer, Tom Le ; Rosain, Jérémie ; Philippot, Quentin; Manry, Jérémy ; Michailidis, Eleftherios ; Hoffmann, Hans-Heinrich ; Eto, Shohei; Garcia-Prat, Marina; Bizien, Lucy; Parra-Martínez, Alba; Yang, Rui; Liis, Haljasmägi; Migaud, Mélanie; Särekannu, Karita; Maslovskaja, Julia; Prost, Nicolas de; Tandjaoui-Lambiotte, Yacine; Luyt , Charles-Edouard; Amador-Borrero, Blanca; Alexandre, Gaudet; Poissy, Julien; Morel, Pascal; Richard, Pascale; Cognasse, Fabrice; Troya, Jesus; Trouillet-Assant, Sophie; Belot, Alexandre; Saker, Kahina; Garçon, Pierre; Rivière, Jacques G; Lagier, Jean-Christophe; Gentile, Stéphanie; Rosen, Lindsey B; Shaw, Elana; Morio, Tomohiro; Tanaka, Junko; Dalmau, David; Tharaux, Pierre-Louis; Sene, Damien; Stepanian, Alain; Megarbane, Bruno; Triantafyllia, Vasiliki; Fekkar, Arnaud; Heath, James R; Franco, José Luis; Anaya, Juan-Manuel; Solé-Violán, Jordi; Imberti, Luisa; Biondi, Andrea; Bonfanti, Paolo; Castagnoli, Riccardo; Delmonte, Ottavia M; Zhang, Yu; Snow, Andrew L; Holland, Steven M; Biggs, Catherine M; Moncada-Vélez, Marcela; Arias, Andrés Augusto; Lorenzo, Lazaro; Boucherit, Soraya; Coulibaly, Boubacar; Anglicheau, Dany; Planas, Anna M; Haerynck, Filomeen; Duvlis, Sotirija; Nussbaum, Robert L; Ozcelik, Tayfun; Keles, Sevgi; Bousfiha, Ahmed A; ElBakkouri, Jalila; Ramirez-Santana, Carolina; Paul, Stéphane; Pan-Hammarström, Qiang; Hammarström, Lennart; Dupont, Annabelle; Kurolap, Alina; Metz, Christine N; Aiuti, Alessandro; Casari, Giorgio; Lampasona, Vito; Ciceri, Fabio; Barreiros, Lucila A; Dominguez-Garrido, Elena; Vidigal, Mateus; Zatz, Mayana ; Beek, Diederik van de; Sahanic, Sabina; Tancevski, Ivan; Stepanovskyy, Yurii; Boyarchuk, Oksana; Nukui, Yoko; Tsumura, Miyuki; Vidaur, Loreto; Tangye, Stuart G; Burrel, Sonia; Duffy, Darragh; Quintana-Murci, Lluis; Klocperk, Adam; Kann, Nelli Y; Shcherbina, Anna; Lau, Yu-Lung; Leung, Daniel; Coulongeat, Matthieu; Marlet, Julien; Koning, Rutger; Reyes, Luis Felipe; Chauvineau-Grenier, Angélique; Vene, Fabienne; Monneret, Guillaume; Nussenzweig, Michel C; Arrestier, Romain; Boudhabhay, Idris; Baris-Feldman, Hagit; Hagin, David; Wauters, Joost; Meyts, Isabelle; Dyer, Adam H; Kennelly, Sean P; Bourke, Nollaig M; Halwani, Rabih; Sharif-Askari, Narjes Saheb; Dorgham, Karim; Sallette, Jérome; Sedkaoui, Souad Mehlal; AlKhater, Suzan; Rigo-Bonnin, Raúl; Morandeira, Francisco; Roussel, Lucie; Vinh, Donald C; Ostrowski, Sisse Rye; Condino Neto, Antonio ; Prando, Carolina ; Bondarenko, Anastasiia; Spaan, András N; Gilardin, Laurent; Fellay, Jacques; Lyonnet, Stanislas; Bilguvar, Kaya; Lifton, Richard P; Mane, Shrikant; Anderson, Mark S; Boisson, Bertrand; Béziat, Vivien; Zhang, Shen-Ying; Andreakos, Evangelos; Hermine, Olivier; Pujol, Aurora; Peterson, Pärt; Mogensen, Trine; H Rowen, Lee; Mond, James; Debette, Stéphanie; Lamballerie, Xavier de; Duval, Xavier; Mentré, France; Zins, Marie; Soler-Palacin, Pere; Colobran, Roger; Gorochov, Guy; Solanich, Xavier; Susen, Sophie; Martinez-Picado, Javier; Raoult, Didier; Vasse, Marc; Gregersen, Peter K; Piemonti, Lorenzo; Rodríguez-Gallego, Carlos; Notarangelo, Luigi D; Su, Helen C; Kisand, Kai; Okada, Satoshi; Puel, Anne; Jouanguy, Emmanuelle; Rice, Charles M; Tiberghien, Pierre; Zhang, Qian; Cobat, Aurélie; Abel, Laurent; Casanova, Jean-Laurent
Fonte: Science Immunology. Unidades: IB, ICB
Assuntos: COVID-19, INFECÇÕES POR CORONAVIRUS, ANTICORPOS, IMUNOLOGIA, HOMENS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTARD, Paul et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, v. 6, n. 62, p. 1-30, 2021Tradução . . Disponível em: https://doi.org/10.1126/sciimmunol.abl4340. Acesso em: 14 nov. 2024.
APA
Bastard, P., Gervais, A., Voyer, T. L., Rosain, J., Philippot, Q., Manry, J., et al. (2021). Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, 6( 62), 1-30. doi:10.1126/sciimmunol.abl4340
NLM
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Vancouver
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Artigo de periodico
Depletion of TAX1BP1 amplifies innate immune responses during Respiratory Syncytial Virus infection (2021)
Descamps, Delphyne ; Oliveira, Andressa Peres de ; Gonnin, Lorène ; Madrières, Sarah; Fix, Jenna; Drajac, Carole ; Marquant, Quentin ; Bouguyon, Edwige; Pietralunga, Vincent; Iha, Hidekatsu ; Ventura, Armando Morais ; Tangy, Frédéric ; Vidalain, Pierre-Olivier ; Eléouët, Jean-François ; Galloux, Marie
Fonte: Journal of Virology. Unidade: ICB
Assuntos: MICROBIOLOGIA, REPLICAÇÃO VIRAL, INFECÇÕES RESPIRATÓRIAS, INFECÇÕES POR VÍRUS DE RNA, HAMSTERS, IMUNIDADE NATURAL, ONCOPROTEÍNAS, INTERFERONS, LEVEDURAS, ANTIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DESCAMPS, Delphyne et al. Depletion of TAX1BP1 amplifies innate immune responses during Respiratory Syncytial Virus infection. Journal of Virology, v. 95, n. 22, p. 1-16, 2021Tradução . . Disponível em: https://doi.org/10.1128/JVI.00912-21. Acesso em: 14 nov. 2024.
APA
Descamps, D., Oliveira, A. P. de, Gonnin, L., Madrières, S., Fix, J., Drajac, C., et al. (2021). Depletion of TAX1BP1 amplifies innate immune responses during Respiratory Syncytial Virus infection. Journal of Virology, 95( 22), 1-16. doi:10.1128/JVI.00912-21
NLM
Descamps D, Oliveira AP de, Gonnin L, Madrières S, Fix J, Drajac C, Marquant Q, Bouguyon E, Pietralunga V, Iha H, Ventura AM, Tangy F, Vidalain P-O, Eléouët J-F, Galloux M. Depletion of TAX1BP1 amplifies innate immune responses during Respiratory Syncytial Virus infection [Internet]. Journal of Virology. 2021 ; 95( 22): 1-16.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1128/JVI.00912-21
Vancouver
Descamps D, Oliveira AP de, Gonnin L, Madrières S, Fix J, Drajac C, Marquant Q, Bouguyon E, Pietralunga V, Iha H, Ventura AM, Tangy F, Vidalain P-O, Eléouët J-F, Galloux M. Depletion of TAX1BP1 amplifies innate immune responses during Respiratory Syncytial Virus infection [Internet]. Journal of Virology. 2021 ; 95( 22): 1-16.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1128/JVI.00912-21

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Assuntos

Título da fonte

Agência de fomento

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos